NCT00498368 Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Status COMPLETED Phase PHASE4
NCT00490490 Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy Status TERMINATED Phase PHASE2
NCT00490334 Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer Status COMPLETED Phase N/A
NCT00486824 Indomethacin Versus Nifedipine for Preterm Labor Tocolysis Status COMPLETED Phase PHASE1/PHASE2
NCT00482157 Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance Status WITHDRAWN Phase NA
NCT00482053 Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT Status TERMINATED Phase PHASE2
NCT00481845 Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer Status TERMINATED Phase PHASE2
NCT00481832 Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00478465 Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) Status COMPLETED Phase PHASE1/PHASE2
NCT00477139 A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer Status COMPLETED Phase N/A
NCT00477087 Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer Status TERMINATED Phase PHASE2
NCT00476775 Ethnic Dance and Screen Time Reduction to Prevent Weight Gain in Latina Girls Status COMPLETED Phase NA
NCT00473005 Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast Status TERMINATED Phase PHASE1